Cargando…

Naming error in multiple sclerosis patients: A pilot study in Isfahan, Iran

BACKGROUND: Although cognitive impairment is common in multiple sclerosis (MS) patients, language difficulties are controversy and little information is available on nonEnglish languages. Therefore, the present cross-sectional study was conducted to assess the naming accuracy in Persian relapsing-re...

Descripción completa

Detalles Bibliográficos
Autores principales: Shamsian, Fereshteh, Dastjerdi, Roshanak Mehdipour, Kavosh, Arian, Ashtari, Fereshteh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6950351/
https://www.ncbi.nlm.nih.gov/pubmed/31949456
http://dx.doi.org/10.4103/jrms.JRMS_497_18
_version_ 1783486051816308736
author Shamsian, Fereshteh
Dastjerdi, Roshanak Mehdipour
Kavosh, Arian
Ashtari, Fereshteh
author_facet Shamsian, Fereshteh
Dastjerdi, Roshanak Mehdipour
Kavosh, Arian
Ashtari, Fereshteh
author_sort Shamsian, Fereshteh
collection PubMed
description BACKGROUND: Although cognitive impairment is common in multiple sclerosis (MS) patients, language difficulties are controversy and little information is available on nonEnglish languages. Therefore, the present cross-sectional study was conducted to assess the naming accuracy in Persian relapsing-remitting MS (RRMS) patients. MATERIALS AND METHODS: Thirty RRMS patients were recruited from Kashani Comprehensive MS Center, Isfahan, Iran. Their performance on measures of mini mental state examination (MMSE), Expanded Disability Status Scale, and Naming Test was compared with control participants. RESULTS: MS patients were found to have much more naming errors than the control group (2.1 ± 1.8 vs. 0.54 ± 1.1 P = 0.02). Average MMSE score of MS patients was 27.23 (range = 18–30, standard deviation [SD] = 2) versus 28.96 (range = 19–30, SD = 3.2) in controls. CONCLUSION: The present study suggests that naming ability can be impaired in RRMS regardless of disability score. Specific language function tests including naming should be considered in the process of evaluating and rehabilitating patients with MS.
format Online
Article
Text
id pubmed-6950351
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-69503512020-01-16 Naming error in multiple sclerosis patients: A pilot study in Isfahan, Iran Shamsian, Fereshteh Dastjerdi, Roshanak Mehdipour Kavosh, Arian Ashtari, Fereshteh J Res Med Sci Short Communication BACKGROUND: Although cognitive impairment is common in multiple sclerosis (MS) patients, language difficulties are controversy and little information is available on nonEnglish languages. Therefore, the present cross-sectional study was conducted to assess the naming accuracy in Persian relapsing-remitting MS (RRMS) patients. MATERIALS AND METHODS: Thirty RRMS patients were recruited from Kashani Comprehensive MS Center, Isfahan, Iran. Their performance on measures of mini mental state examination (MMSE), Expanded Disability Status Scale, and Naming Test was compared with control participants. RESULTS: MS patients were found to have much more naming errors than the control group (2.1 ± 1.8 vs. 0.54 ± 1.1 P = 0.02). Average MMSE score of MS patients was 27.23 (range = 18–30, standard deviation [SD] = 2) versus 28.96 (range = 19–30, SD = 3.2) in controls. CONCLUSION: The present study suggests that naming ability can be impaired in RRMS regardless of disability score. Specific language function tests including naming should be considered in the process of evaluating and rehabilitating patients with MS. Wolters Kluwer - Medknow 2019-12-23 /pmc/articles/PMC6950351/ /pubmed/31949456 http://dx.doi.org/10.4103/jrms.JRMS_497_18 Text en Copyright: © 2019 Journal of Research in Medical Sciences http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Short Communication
Shamsian, Fereshteh
Dastjerdi, Roshanak Mehdipour
Kavosh, Arian
Ashtari, Fereshteh
Naming error in multiple sclerosis patients: A pilot study in Isfahan, Iran
title Naming error in multiple sclerosis patients: A pilot study in Isfahan, Iran
title_full Naming error in multiple sclerosis patients: A pilot study in Isfahan, Iran
title_fullStr Naming error in multiple sclerosis patients: A pilot study in Isfahan, Iran
title_full_unstemmed Naming error in multiple sclerosis patients: A pilot study in Isfahan, Iran
title_short Naming error in multiple sclerosis patients: A pilot study in Isfahan, Iran
title_sort naming error in multiple sclerosis patients: a pilot study in isfahan, iran
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6950351/
https://www.ncbi.nlm.nih.gov/pubmed/31949456
http://dx.doi.org/10.4103/jrms.JRMS_497_18
work_keys_str_mv AT shamsianfereshteh namingerrorinmultiplesclerosispatientsapilotstudyinisfahaniran
AT dastjerdiroshanakmehdipour namingerrorinmultiplesclerosispatientsapilotstudyinisfahaniran
AT kavosharian namingerrorinmultiplesclerosispatientsapilotstudyinisfahaniran
AT ashtarifereshteh namingerrorinmultiplesclerosispatientsapilotstudyinisfahaniran